Trial Profile
Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer BMS#CA225091
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 29 Jul 2013 New source identified and integrated: ClinialTrials.gov record NCT01904435.
- 29 Jul 2013 New source identified and integrated: ClinialTrials.gov record NCT01904435.
- 26 May 2010 Actual end date (April 2010) added as reported by ClinicalTrials.gov.